CPAP AND SURFACTANT
Randomized clinical trials suggest that nasal CPAP is acceptable as an alter- native to surfactant administration in preterm infants with RDS. A clinical report from the American Academy of Pediatrics, “Respiratory Support of the Preterm Infant,” is forthcoming.